{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T01:34:28Z","timestamp":1790732068515,"version":"4.1.0"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T00:00:00Z","timestamp":1666483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008069","name":"UCSF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.neo.2022.100851","type":"journal-article","created":{"date-parts":[[2022,11,18]],"date-time":"2022-11-18T06:58:46Z","timestamp":1668754726000},"page":"100851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Interdisciplinary care of children with diffuse midline glioma"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5747-4045","authenticated-orcid":false,"given":"Christina","family":"Coleman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5146-2665","authenticated-orcid":false,"given":"Katherine","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1606-6306","authenticated-orcid":false,"given":"Alex","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4971-5475","authenticated-orcid":false,"given":"Elizabeth","family":"Seashore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1931-7521","authenticated-orcid":false,"given":"Schuyler","family":"Stoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taron","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Braunstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9539-7052","authenticated-orcid":false,"given":"Nalin","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3452-5150","authenticated-orcid":false,"given":"Sabine","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0001","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/neuonc\/noaa295","article-title":"Epidemiology of brainstem high-grade gliomas in children and adolescents in the United States, 2000-2017","volume":"23","author":"Patil","year":"2021","journal-title":"Neuro Oncol"},{"issue":"9","key":"10.1016\/j.neo.2022.100851_bib0002","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/neuonc\/nox107","article-title":"Contemporary survival endpoints: an International Diffuse Intrinsic Pontine Glioma Registry study","volume":"19","author":"Cooney","year":"2017","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/neuonc\/nox149","article-title":"Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor location","volume":"20","author":"Karremann","year":"2018","journal-title":"Neuro Oncol"},{"issue":"7384","key":"10.1016\/j.neo.2022.100851_bib0004","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0005","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0006","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0007","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00401-020-02142-w","article-title":"Histone H3 wild-type DIPG\/DMG overexpressing EZHIP extend the spectrum diffuse midline gliomas with PRC2 inhibition beyond H3-K27M mutation","volume":"139","author":"Castel","year":"2020","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.neo.2022.100851_bib0008","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0009","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1586\/14737140.2015.974563","article-title":"A twenty-year review of diagnosing and treating children with diffuse intrinsic pontine glioma in The Netherlands","volume":"15","author":"Veldhuijzen van Zanten","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0010","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s11060-010-0301-y","article-title":"Prospective neuraxis MRI surveillance reveals a high risk of leptomeningeal dissemination in diffuse intrinsic pontine glioma","volume":"102","author":"Sethi","year":"2011","journal-title":"J Neurooncol"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0011","doi-asserted-by":"crossref","first-page":"e317","DOI":"10.1016\/S1470-2045(20)30173-X","article-title":"Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group","volume":"21","author":"Erker","year":"2020","journal-title":"Lancet Oncol"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0012","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1016\/S1470-2045(20)30166-2","article-title":"Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group","volume":"21","author":"Cooney","year":"2020","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0013","first-page":"vdac100","article-title":"Does a Bevacizumab-based regime have a role in the treatment of children with diffuse intrinsic pontine glioma? A systematic review","volume":"4","author":"Evans","year":"2022","journal-title":"Neurooncol Adv"},{"issue":"7","key":"10.1016\/j.neo.2022.100851_bib0014","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1002\/ijc.32258","article-title":"A pilot precision medicine trial for children with diffuse intrinsic pontine glioma-PNOC003: A report from the Pacific Pediatric Neuro-Oncology Consortium","volume":"145","author":"Mueller","year":"2019","journal-title":"Int J Cancer"},{"issue":"suppl_6","key":"10.1016\/j.neo.2022.100851_bib0015","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noy148.834","article-title":"Pdct-04. phase 1 trial of wee1 kinase inhibitor azd1775 combined with radiation therapy for children with newly diagnosed diffuse intrinsic pontine glioma: a report from the children's oncology group phase 1 pilot consortium (advl1217)","volume":"20","author":"Mueller","year":"2018","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neo.2022.100851_bib0016","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-22-0803","article-title":"Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003","author":"Kline","year":"2022","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0017","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1038\/s41598-020-67764-2","article-title":"Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas","volume":"10","author":"Kambhampati","year":"2020","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0018","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1080\/08880018.2020.1759738","article-title":"Characteristics of parental decision-making for children with advanced cancer who are offered enrollment in early-phase clinical trials: A systematic review","volume":"37","author":"Le Rouzic","year":"2020","journal-title":"Pediatr Hematol Oncol"},{"issue":"20","key":"10.1016\/j.neo.2022.100851_bib0019","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1002\/cncr.30090","article-title":"Access to Children's Oncology Group and Pediatric Brain Tumor Consortium phase 1 clinical trials: Racial\/ethnic dissimilarities in participation","volume":"122","author":"Nooka","year":"2016","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.neo.2022.100851_bib0020","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/pbc.25472","article-title":"Participation in pediatric oncology research protocols: Racial\/ethnic, language and age-based disparities","volume":"62","author":"Aristizabal","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0021","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/cncr.32675","article-title":"Systematic review of barriers and facilitators to clinical trial enrollment among adolescents and young adults with cancer: Identifying opportunities for intervention","volume":"126","author":"Siembida","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0022","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/jayao.2021.0041","article-title":"Barriers to Pediatric Oncologist Enrollment of Adolescents and Young Adults on a Cross-Network National Clinical Trials Network Supportive Care Cancer Clinical Trial","volume":"11","author":"Mittal","year":"2022","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"21","key":"10.1016\/j.neo.2022.100851_bib0023","doi-asserted-by":"crossref","first-page":"7620","DOI":"10.1002\/cam4.4292","article-title":"Patterns of National Cancer Institute-Sponsored Clinical Trial Enrollment in Black Adolescents and Young Adults","volume":"10","author":"Roth","year":"2021","journal-title":"Cancer Med"},{"issue":"9","key":"10.1016\/j.neo.2022.100851_bib0024","doi-asserted-by":"crossref","first-page":"e29061","DOI":"10.1002\/pbc.29061","article-title":"Complementary and alternative medicine in children with diffuse intrinsic pontine glioma-A SIOPE DIPG Network and Registry study","volume":"68","author":"El-Khouly","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamaoncol.2016.0155","article-title":"Medical marijuana use in oncology: A review","volume":"2","author":"Wilkie","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.neo.2022.100851_bib0026","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noac209.158","article-title":"Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma","author":"Messinger","year":"2022","journal-title":"Neuro Oncol"},{"issue":"18","key":"10.1016\/j.neo.2022.100851_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/nu14183851","article-title":"Ketogenic diet in the treatment of gliomas and glioblastomas","volume":"14","author":"Dal Bello","year":"2022","journal-title":"Nutrients"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0028","first-page":"e1383","article-title":"Ketogenic diet treatment in diffuse intrinsic pontine glioma in children: Retrospective analysis of feasibility, safety, and survival data","volume":"4","author":"Perez","year":"2021","journal-title":"Cancer Rep (Hoboken)"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0029","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/pbc.25266","article-title":"Time to rethink the unthinkable: upfront biopsy of children with newly diagnosed diffuse intrinsic pontine glioma (DIPG)","volume":"62","author":"Kieran","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0030","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuchi.2020.05.007","article-title":"Diffuse infiltrative pontine glioma biopsy in children with neuronavigation, frameless procedure: A single center experience of 10 cases","volume":"66","author":"Joud","year":"2020","journal-title":"Neurochirurgie"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0031","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/pbc.25224","article-title":"Diffuse intrinsic pontine glioma biopsy: a single institution experience","volume":"62","author":"Wang","year":"2015","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0032","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.2936","article-title":"Genomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutations","volume":"46","author":"Buczkowicz","year":"2014","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0033","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nm.3855","article-title":"Functionally defined therapeutic targets in diffuse intrinsic pontine glioma","volume":"21","author":"Grasso","year":"2015","journal-title":"Nat Med"},{"issue":"8","key":"10.1016\/j.neo.2022.100851_bib0034","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/neuonc\/now299","article-title":"The transcription factor Olig2 is important for the biology of diffuse intrinsic pontine gliomas","volume":"19","author":"Anderson","year":"2017","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.neo.2022.100851_bib0035","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162283","article-title":"Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma","volume":"132","author":"Mueller","year":"2022","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.neo.2022.100851_bib0036","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1093\/neuonc\/noz022","article-title":"Molecular profiling and targeted therapy in pediatric gliomas: review and consensus recommendations","volume":"21","author":"Miklja","year":"2019","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.neo.2022.100851_bib0037","doi-asserted-by":"crossref","first-page":"629","DOI":"10.14694\/EdBook_AM.2012.32.59","article-title":"Is biopsy safe in children with newly diagnosed diffuse intrinsic pontine glioma?","author":"Puget","year":"2012","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"11","key":"10.1016\/j.neo.2022.100851_bib0038","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1093\/neuonc\/noy070","article-title":"Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma","volume":"20","author":"Gupta","year":"2018","journal-title":"Neuro Oncol"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/2017.2.PEDS1665","article-title":"Update on the diagnostic value and safety of stereotactic biopsy for pediatric brainstem tumors: a systematic review and meta-analysis of 735 cases","volume":"20","author":"Hamisch","year":"2017","journal-title":"J Neurosurg Pediatr"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0040","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3171\/2018.6.PEDS17658","article-title":"Tumor dissemination through surgical tracts in diffuse intrinsic pontine glioma","volume":"22","author":"Lobon-Iglesias","year":"2018","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.neo.2022.100851_bib0041","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejca.2019.03.019","article-title":"Brainstem biopsy in pediatric diffuse intrinsic pontine glioma in the era of precision medicine: the INFORM study experience","volume":"114","author":"Pfaff","year":"2019","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0042","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3171\/2020.4.PEDS2092","article-title":"Safety and efficacy of brainstem biopsy in children and young adults","volume":"26","author":"Hersh","year":"2020","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.neo.2022.100851_bib0043","first-page":"1","article-title":"Ventricular size determination and management of ventriculomegaly and hydrocephalus in patients with diffuse intrinsic pontine glioma: an institutional experience","author":"Fonseca","year":"2021","journal-title":"J Neurosurg"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0044","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2019.10.FOCUS19679","article-title":"Deformational changes after convection-enhanced delivery in the pediatric brainstem","volume":"48","author":"Bander","year":"2020","journal-title":"Neurosurg Focus"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0045","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s00381-019-04069-4","article-title":"Diffuse intrinsic pontine glioma ventricular peritoneal shunt metastasis: a case report and literature review","volume":"35","author":"Gelder","year":"2019","journal-title":"Childs Nerv Syst"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2009.02.048","article-title":"Endoscopic third ventriculostomy in the treatment of childhood hydrocephalus","volume":"155","author":"Kulkarni","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/j.neo.2022.100851_bib0047","article-title":"Safety and efficacy of Endoscopic Third Ventriculostomy in Diffuse Intrinsic Pontine Glioma related hydrocephalus: a Systematic Review","author":"Guida","year":"2018","journal-title":"World Neurosurg"},{"issue":"7903","key":"10.1016\/j.neo.2022.100851_bib0048","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/s41586-022-04489-4","article-title":"GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas","volume":"603","author":"Majzner","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0049","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00263825","article-title":"Management of pediatric pontine gliomas","volume":"7","author":"Langmoen","year":"1991","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0050","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0051","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s11060-020-03415-w","article-title":"Radiation dose response of neurologic symptoms during conformal radiotherapy for diffuse intrinsic pontine glioma","volume":"147","author":"Tinkle","year":"2020","journal-title":"J Neurooncol"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0052","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2022.01.054","article-title":"Hypofractionated radiation therapy for diffuse intrinsic pontine glioma: A noninferiority randomized study including 253 children","volume":"113","author":"Zaghloul","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0053","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.ijrobp.2008.05.030","article-title":"The role of hypofractionation radiotherapy for diffuse intrinsic brainstem glioma in children: a pilot study","volume":"73","author":"Janssens","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.neo.2022.100851_bib0054","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.3109\/0284186X.2014.957414","article-title":"Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy","volume":"53","author":"Indelicato","year":"2014","journal-title":"Acta Oncol"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0055","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ijrobp.2017.11.026","article-title":"Brainstem injury in pediatric patients with posterior fossa tumors treated with proton beam therapy and associated dosimetric factors","volume":"100","author":"Gentile","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0056","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.ijrobp.2019.08.039","article-title":"Brainstem injury in pediatric patients receiving posterior fossa photon radiation","volume":"105","author":"Devine","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0057","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2018.01.013","article-title":"National cancer institute workshop on proton therapy for children: considerations regarding brainstem injury","volume":"101","author":"Haas-Kogan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.neo.2022.100851_bib0058","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/ACO.0b013e328347f931","article-title":"Sedation and anesthesia for the pediatric patient undergoing radiation therapy","volume":"24","author":"McFadyen","year":"2011","journal-title":"Curr Opin Anaesthesiol"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0059","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ijrobp.2007.09.044","article-title":"Safe anesthesia for radiotherapy in pediatric oncology: St. Jude Children's Research Hospital Experience, 2004-2006","volume":"71","author":"Anghelescu","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0060","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijrobp.2020.09.002","article-title":"Improving the Pediatric Patient Experience During Radiation Therapy-A Children's Oncology Group Study","volume":"109","author":"Holt","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0061","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-016-2151-8","article-title":"Pseudoprogression in children, adolescents and young adults with non-brainstem high grade glioma and diffuse intrinsic pontine glioma","volume":"129","author":"Carceller","year":"2016","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.neo.2022.100851_bib0062","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.ijrobp.2008.12.032","article-title":"Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas","volume":"75","author":"Liu","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0063","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.adro.2019.03.009","article-title":"Role of radiation therapy in the management of diffuse intrinsic pontine glioma: A systematic review","volume":"4","author":"Gallitto","year":"2019","journal-title":"Adv Radiat Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0064","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2018.12.043","article-title":"A phase 1\/2 trial of reirradiation for diffuse intrinsic pontine glioma","volume":"104","author":"Amsbaugh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1016\/j.neo.2022.100851_bib0065","doi-asserted-by":"crossref","first-page":"e26988","DOI":"10.1002\/pbc.26988","article-title":"Reirradiation in patients with diffuse intrinsic pontine gliomas: The Canadian experience","volume":"65","author":"Lassaletta","year":"2018","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.neo.2022.100851_bib0066","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00381-019-04118-y","article-title":"Reirradiation for diffuse intrinsic pontine glioma: a systematic review and meta-analysis","volume":"35","author":"Lu","year":"2019","journal-title":"Childs Nerv Syst"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0067","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0360-3016(00)00471-5","article-title":"A detrimental effect of a combined chemotherapy-radiotherapy approach in children with diffuse intrinsic brain stem gliomas?","volume":"47","author":"Freeman","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.neo.2022.100851_bib0068","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11060-008-9525-5","article-title":"Diffuse pontine gliomas in children: changing strategies, changing results? A mono-institutional 20-year experience","volume":"87","author":"Massimino","year":"2008","journal-title":"J Neurooncol"},{"issue":"4","key":"10.1016\/j.neo.2022.100851_bib0069","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children's Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0070","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40141-019-00218-7","article-title":"Rehabilitation considerations in pediatric brain tumors","volume":"7","author":"Pruitt","year":"2019","journal-title":"Curr Phys Med Rehabil Rep"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0071","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/MPH.0000000000001844","article-title":"Exercise trials in pediatric brain tumor: A systematic review of randomized studies","volume":"43","author":"Sharma","year":"2021","journal-title":"J Pediatr Hematol Oncol"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0072","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000567","article-title":"Paediatric neuro-oncology rehabilitation in the UK: carer and provider perspectives","volume":"3","author":"Treadgold","year":"2019","journal-title":"bmjpo"},{"issue":"5 Suppl 1","key":"10.1016\/j.neo.2022.100851_bib0073","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1097\/PHM.0b013e31820be31f","article-title":"Brain tumor rehabilitation","volume":"90","author":"Vargo","year":"2011","journal-title":"Am J Phys Med Rehabil"},{"issue":"13","key":"10.1016\/j.neo.2022.100851_bib0074","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1044\/persp1.SIG13.143","article-title":"Dysphagia and Long-Term Feeding Difficulties in the Pediatric Brain Tumor Population","volume":"1","author":"Kilcommons","year":"2016","journal-title":"Perspect ASHA Spec Interest Groups"},{"issue":"4","key":"10.1016\/j.neo.2022.100851_bib0075","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1089\/jpm.1999.2.425.2","article-title":"Cancer Pain Relief and Palliative Care in ChildrenCancer Pain Relief and Palliative Care in Children. World Health Organization, 1998, 76 pp. (available in English; French and Spanish in preparation). US $16.20; ISBN 922 4 1545127","volume":"2","author":"Chaffee","year":"1999","journal-title":"J Palliat Med"},{"issue":"4","key":"10.1016\/j.neo.2022.100851_bib0076","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/neuonc\/nov250","article-title":"Palliative and end-of-life care for children with diffuse intrinsic pontine glioma: results from a London cohort study and international survey","volume":"18","author":"Veldhuijzen van Zanten","year":"2016","journal-title":"Neuro Oncol"},{"issue":"12","key":"10.1016\/j.neo.2022.100851_bib0077","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMoa040366","article-title":"Talking about death with children who have severe malignant disease","volume":"351","author":"Kreicbergs","year":"2004","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neo.2022.100851_bib0078","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/bmjspcare-2012-000419","article-title":"The challenges and suffering of caring for people with primary malignant glioma: qualitative perspectives on improving current supportive and palliative care practices","volume":"4","author":"Collins","year":"2014","journal-title":"BMJ Support Palliat Care"},{"key":"10.1016\/j.neo.2022.100851_bib0079","article-title":"Early palliative interventions for improving outcomes in people with a primary malignant brain tumour and their carers","volume":"1","author":"Byrne","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.neo.2022.100851_bib0080","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JOP.2016.017897","article-title":"Integration of palliative care into standard oncology care: ASCO clinical practice guideline update summary","volume":"13","author":"Ferrell","year":"2017","journal-title":"J Oncol Pract"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:11:51Z","timestamp":1761484311000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":80,"alternative-id":["S1476558622000744"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100851","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interdisciplinary care of children with diffuse midline glioma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100851"}}